Redmile Group, LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 211 filers reported holding NEVRO CORP in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q2 2022$17,774,000
-40.2%
405,517
-1.3%
0.68%
-26.8%
Q1 2022$29,729,000
+35.8%
411,017
+52.2%
0.93%
+86.3%
Q4 2021$21,898,000
-65.3%
270,116
-50.2%
0.50%
-54.8%
Q3 2021$63,186,000
-35.9%
542,932
-8.7%
1.10%
-24.5%
Q2 2021$98,601,000
+36.8%
594,732
+15.1%
1.46%
+43.7%
Q1 2021$72,093,000
-6.2%
516,795
+16.4%
1.02%
+9.1%
Q4 2020$76,841,000
+20.0%
443,909
-3.4%
0.93%
-20.9%
Q3 2020$64,024,000
+7.7%
459,609
-7.7%
1.18%
+7.0%
Q2 2020$59,468,000
-15.8%
497,764
-29.5%
1.10%
-44.5%
Q1 2020$70,628,000
-36.0%
706,426
-24.8%
1.98%
-25.0%
Q4 2019$110,389,000
+99.4%
939,164
+45.9%
2.64%
+42.5%
Q3 2019$55,353,000
+25060.5%
643,864
+18837.2%
1.85%
+30766.7%
Q2 2019$220,000
+3.3%
3,4000.0%0.01%0.0%
Q1 2019$213,000
-21.4%
3,4000.0%0.01%
-33.3%
Q2 2018$271,000
-98.6%
3,400
-98.7%
0.01%
-99.4%
Q4 2016$18,919,000
-20.3%
260,380
+14.6%
1.63%
-13.6%
Q3 2016$23,724,000
-19.3%
227,267
-43.0%
1.89%
-32.8%
Q2 2016$29,384,000
+300.0%
398,371
+205.1%
2.81%
+273.3%
Q1 2016$7,346,000
-73.8%
130,571
-68.6%
0.75%
-64.2%
Q4 2015$28,030,000
+2316.4%
415,198
+1560.8%
2.10%
+2284.1%
Q3 2015$1,160,000
-87.2%
25,000
-89.3%
0.09%
-91.1%
Q4 2014$9,059,000234,2540.99%
Other shareholders
NEVRO CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Iron Triangle Partners LP 562,833$40,710,0004.84%
Altium Capital Management LP 77,000$5,569,0001.86%
PFM Health Sciences, LP 649,513$46,979,0001.76%
Rock Springs Capital Management LP 721,500$52,186,0001.31%
Integral Health Asset Management, LLC 50,000$3,617,0000.94%
Redmile Group, LLC 411,017$29,729,0000.93%
K2 PRINCIPAL FUND, L.P. 114,800$8,303,0000.72%
Connacht Asset Management LP 18,762$1,357,0000.70%
Perceptive Advisors 477,037$34,504,0000.69%
ArrowMark Colorado Holdings LLC 855,439$61,874,0000.54%
View complete list of NEVRO CORP shareholders